28.01.2020 | Tracker

EMA Approvals tracker: HCPs anticipating 2020 approvals

By Laura McIntyre

EMA Approvals tracker: HCPs anticipating 2020 approvals

Even though quieter during the holidays, the online HCP conversation relating to EMA approvals still spiked following key EMA decisions.

HCPs quickly responded to Janssen’s Spravato (esketamine) receiving EMA approval for treatment-resistant major depressive disorder in adults. They shared a BMJ article reporting the news and a press release from Business Wire.

Out of 37 product-related mentions over the time period, the Spravato approval was mentioned 21 times.

Other approvals discussed by HCPs included looking back at Merck’s Ebola vaccine Ervebo approval that happened back in October and BMS Revlimid (lenalidomide) combination with rituximab for the treatment of relapsed or refractory follicular lymphoma.

HCPs in UK foresee challenges while awaiting EMA approvals

HCPs also showed anticipation for some of the novel therapies being approved by EMA in the near future. UK HCPs stated that the UK needs Trikafta (elexacaftor, ivacaftor and tezacaftor), a new breakthrough therapy for cystic fibrosis, as soon as it is approved in Europe, and wondered how Brexit is going to affect the access to the medicine.

Another anticipated EMA approval is Enhertu (trastuzumab deruxtecan), a metastatic breast cancer treatment by AstraZeneca. HCPs encouraged one another that the EMA approval will soon follow, but admitted there may be a challenge getting it on the NHS.

We are tracking the HCP reaction to EMA approvals and related topics each month. You can keep up to date with this and other pharmaceutical tracking updates, including FDA drug approvals, within the Tracking section of CREATION Knowledge or by signing up our monthly newsletter.


New EMA approval in rheumatoid arthritis catches HCP attention

Methodology notes:

  • Data for this research was analysed from the online Twitter conversations of HCPs talking about EMA approvals in English language (all other languages are available), between December 15th 2019 and January 14th 2020.
  • Between December 15th 2019 and January 14th 2020, 59 HCPs posted relating to EMA approvals 76 times all over the world.

View all articles >

Meet the Author

Laura McIntyre

Suggested next

02.11.2020 | Article

Top 50 Pharma Tracker: Regeneron tops list due to high profile COVID-19 treatment conversation

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Mary Kangley

24.10.2022 | Article

Respiratory tracker: HCPs discuss inhaler technique during #askaboutasthma and react to patients’ response to cost of living crisis

This month UK HCPs were most active on 04 October, posting about respiratory diseases 325 ti

By Mark Sullivan

View all articles >